index: hide
name: Complications of Cancer Treatment


Treatment for cancers, whether it be surgical, chemotherapy, radiation, immunotherapy or some type of other therapy, oftentimes has complications. Codes for complications due to these different types of therapy have been greatly expanded for ICD-10-CM.

<table class="table table-striped">
	<tbody><tr>
		<th width="20%" scope="col">ICD-10-CM Code</th>
		<th scope="col">ICD-10-CM Description</th>
	</tr>
	<tr>
		<td>D61.1</td>
		<td>Drug-induced  aplastic anemia (aplastic anemia due to antineoplastic chemotherapy)</td>
	</tr>
	<tr>
		<td>D61.810</td>
		<td>Antineoplastic  chemotherapy induced pancytopenia</td>
	</tr>
	<tr>
		<td>D64.81</td>
		<td>Anemia  due to antineoplastic chemotherapy</td>
	</tr>
	<tr>
	  <td>D70.1</td>
	  <td>Agranulocytosis  secondary to cancer chemotherapy</td>
    </tr>
	<tr>
	  <td>J34.81</td>
	  <td>Nasal  mucositis (ulcerative) (due to antineoplastic and immunosuppressive drugs)</td>
    </tr>
	<tr>
	  <td>K12.31</td>
	  <td>Oral  mucositis (ulcerative) due to antineoplastic therapy </td>
    </tr>
	<tr>
	  <td>K12.33</td>
	  <td>Oral  mucositis (ulcerative) due to radiation</td>
    </tr>
	<tr>
	  <td>K62.7</td>
	  <td>Radiation  proctitis</td>
    </tr>
	<tr>
	  <td>K92.81</td>
	  <td>Gastrointestinal  mucositis (ulcerative)(due to antineoplastic and immunosuppressive drugs)</td>
    </tr>
	<tr>
	  <td>N76.81</td>
	  <td>Mucositis  (ulcerative) of vagina and vulva</td>
    </tr>
	<tr>
	  <td>T45.1-</td>
	  <td>Poisoning  by, adverse effect of and under dosing of antineoplastic and immunosuppressive  drugs</td>
    </tr>
	<tr>
	  <td>T38.6-</td>
	  <td>Poisoning by  antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified</td>
    </tr>
	<tr>
	  <td>T38.8-,  T38.9-</td>
	  <td>Poisoning by hormones  and their synthetic substitutes</td>
    </tr>
	<tr>
	  <td>T45.1-</td>
	  <td>Poisoning by, adverse  effect of and under dosing of antineoplastic and immunosuppressive drugs</td>
    </tr>
	<tr>
	  <td>T45.8-,  T45.9-</td>
	  <td>Poisoning  by systemic hematological agent</td>
    </tr>
	<tr>
	  <td>T66</td>
	  <td>Unspecified  effects of radiation</td>
    </tr>
	<tr>
	  <td>T80.1</td>
	  <td>Vascular  complications following infusion, transfusion and therapeutic injection</td>
    </tr>
	<tr>
	  <td>T80.2-</td>
	  <td>Infections  following infusion, transfusion and therapeutic injections</td>
    </tr>
	<tr>
	  <td>T80.810</td>
	  <td>Extravasation of  vesicant antineoplastic chemotherapy</td>
    </tr>
	<tr>
	  <td>T80.818</td>
	  <td>Extravasation  of other vesicant agent</td>
    </tr>
	<tr>
	  <td>T86.0</td>
	  <td>Complications  of bone marrow transplant</td>
    </tr>
	<tr>
	  <td>Y63.2</td>
	  <td>Overdose  of radiation given during therapy</td>
    </tr>
	<tr>
	  <td>Y84.2</td>
	  <td>Radiological  procedure and radiotherapy as the cause of abnormal reaction of the patient, or  of later complication, without mention of misadventure at the time of the  procedure</td>
    </tr>
  </tbody></table>
